A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer (Q83640526)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 March 2012

Language	Label	Description	Also known as
English	A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer	scientific article published on 13 March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Matthew G Fury

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Nancy Y Lee

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Eric Sherman

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Donna Lisa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Katherine Kelly

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Brynna Lipson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Diane Carlson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Hilda Stambuk

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sofia Haque

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ronglai Shen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Dennis Kraus

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

David G Pfister

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

13 March 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

118

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

5008-5014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

A performance status scale for head and neck cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus in HNSCC: recognition of a distinct disease type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of tonsillar cancer in Sweden is increasing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27498

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27498

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415650%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83640526&oldid=1584442295"